IMMUNOTHERAPY WITH AUTOLOGOUS TUMOR CELL-BCG VACCINE (ONCOVAX®) IN PATIENTS WITH STAGE II COLON CANCER: MEDICAL AND ECONOMIC BENEFITS

Authors

Herbert Hoover

Publication/Presentation Date

2002

Volume

5

Issue

6

First Page

444

Last Page

444

Disciplines

Medicine and Health Sciences

Department(s)

Department of Surgery

Document Type

Article

Share

COinS